UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): December 28, 2011


American Oriental Bioengineering, Inc.
(Exact name of registrant as specified in charter)

Nevada
(State or other jurisdiction of incorporation)

001-32569
84-0605867
(Commission File Number)
(IRS Employer Identification No.)

1 Liangshuihe First Ave, Beijing E-Town Economic and Technology Development Area, E-Town,
Beijing, 100176, People’s Republic of China

 (Address of principal executive offices and zip code)

 
86-10-5982-2039

(Registrant’s telephone number including area code)


(Registrant’s former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 



 
 

 

Item 5.07  Submission of Matters to a Vote of Security Holders.
 
On December 28, 2011, American Oriental Bioengineering, Inc. (the “Company”) held its annual meeting of stockholders (“Annual Meeting”) to vote on the following matters:
 
1.  Election of Directors
 
All of the following seven nominees were elected to the Company’s Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified.
 
Directors
 
For
 
Votes
Withheld
 
Broker Non-Votes
Tony Liu
 
51,640,144
 
1,727,598
 
31,646,392
Jun Min
 
51,691,151
 
1,676,591
 
31,646,392
Yanchun Li
 
50,680,603
 
2,687,139
 
31,646,392
Cosimo J. Patti
 
50,577,162
 
2,790,580
 
31,646,392
Xianmin Wang
 
50,590,190
 
2,777,552
 
31,646,392
Lawrence S. Wizel
 
50,592,509
 
2,775,233
 
31,646,392
Baiqing Zhang
 
51,679,948
 
1,687,794
 
31,646,392
 

 
2.  Ratification of the Company’s Independent Auditors
 
The stockholders of the Company ratified the appointment of Ernst & Young Hua Ming as independent auditors to audit the financial statements of the Company for the fiscal year ending December 31, 2011, in accordance with the voting results listed below.
 
For
 
Votes
Against
 
Abstain
83,779,650
 
1,144,448
 
90,036
 


 
2

 

3.       Stockholders passed an advisory vote to approve the compensation paid to the Company’s named executive officers.

Votes For
 
Votes Against
 
Abstain
 
Broker
Non-Votes
             
50,157,429
 
2,883,573
 
326,740
 
31,646,392


4.       Stockholders passed an advisory vote directing the Company to seek an advisory vote on the compensation of the Company’s named executive officers each year.

Every One Year
 
Every Two Years
 
Every Three Years
 
Abstain
             
52,642,281
 
104,420
 
175,846
 
445,195
 
 
 
 
 
 
 
 

 
 
3

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
AMERICAN ORIENTAL BIOENGINEERING, INC.
 
 
Dated: December 30, 2011
By:  /s/ Tony Liu                                            
  Name: Tony Liu
 
Title: Chairman and Chief Executive Officer
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4